These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34080135)

  • 41. SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection.
    Zervou FN; Louie P; Stachel A; Zacharioudakis IM; Ortiz-Mendez Y; Thomas K; Aguero-Rosenfeld ME
    J Med Virol; 2021 Sep; 93(9):5409-5415. PubMed ID: 33932299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Robust Neutralizing Antibody Levels Detected after Either SARS-CoV-2 Vaccination or One Year after Infection.
    Glöckner S; Hornung F; Baier M; Weis S; Pletz MW; Deinhardt-Emmer S; Löffler B; The CoNAN Study Group
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696428
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased levels of antibodies against heat shock proteins in stroke patients.
    Banecka-Majkutewicz Z; Grabowski M; Kadziński L; Papkov A; Węgrzyn A; Banecki B
    Acta Biochim Pol; 2014; 61(2):379-83. PubMed ID: 24904931
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers.
    Borghi MO; Bombaci M; Bodio C; Lonati PA; Gobbini A; Lorenzo M; Torresani E; Dubini A; Bulgarelli I; Solari F; Pregnolato F; Bandera A; Gori A; Parati G; Abrignani S; Grifantini R; Meroni PL
    Front Immunol; 2022; 13():930074. PubMed ID: 35911726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum heat shock protein and anti-heat shock protein antibody levels in aging.
    Rea IM; McNerlan S; Pockley AG
    Exp Gerontol; 2001 Feb; 36(2):341-52. PubMed ID: 11226747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.
    Huber T; Steininger P; Irrgang P; Korn K; Tenbusch M; Diesch K; Achenbach S; Kremer AE; Werblow M; Vetter M; Bogdan C; Held J
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1983-1997. PubMed ID: 34109500
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreased serum heat shock protein 60 levels in newly diagnosed immune thrombocytopenia patients.
    Dolasik I; Birtas Atesoglu E; Tarkun P; Mehtap O; Keski H; Dogru A; Hacihanefioglu A
    Platelets; 2015; 26(3):220-3. PubMed ID: 24749912
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days.
    Xu QY; Xue JH; Xiao Y; Jia ZJ; Wu MJ; Liu YY; Li WL; Liang XM; Yang TC
    Front Immunol; 2021; 12():786554. PubMed ID: 35003104
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Durability of humoral and cell-mediated immune response after SARS-CoV-2 mRNA vaccine administration.
    Mihaylova A; Lesichkova S; Baleva M; Nikolova-Vlahova M; Kundurzhiev T; Kolevski A; Naumova E
    J Med Virol; 2023 Jan; 95(1):e28360. PubMed ID: 36448089
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
    Desmecht S; Tashkeev A; El Moussaoui M; Marechal N; Perée H; Tokunaga Y; Fombellida-Lopez C; Polese B; Legrand C; Wéry M; Mni M; Fouillien N; Toussaint F; Gillet L; Bureau F; Lutteri L; Hayette MP; Moutschen M; Meuris C; Vermeersch P; Desmecht D; Rahmouni S; Darcis G
    Front Immunol; 2022; 13():863554. PubMed ID: 35711445
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibodies against Spike protein correlate with broad autoantigen recognition 8 months post SARS-CoV-2 exposure, and anti-calprotectin autoantibodies associated with better clinical outcomes.
    Moody R; Sonda S; Johnston FH; Smith KJ; Stephens N; McPherson M; Flanagan KL; Plebanski M
    Front Immunol; 2022; 13():945021. PubMed ID: 36032086
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
    Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
    Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibody Responses to BNT162b2 Vaccination in Japan: Monitoring Vaccine Efficacy by Measuring IgG Antibodies against the Receptor-Binding Domain of SARS-CoV-2.
    Fujigaki H; Yamamoto Y; Koseki T; Banno S; Ando T; Ito H; Fujita T; Naruse H; Hata T; Moriyama S; Takahashi Y; Suzuki T; Murakami T; Yoshida Y; Yagura Y; Oyamada T; Takemura M; Kondo M; Iwata M; Saito K
    Microbiol Spectr; 2022 Feb; 10(1):e0118121. PubMed ID: 35044205
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low levels of heat shock proteins-60 and -65 autoantibodies in Sjögren's syndrome.
    Shovman O; Sherer Y; Gilbourd B; Gerli R; Bocci EB; delle Monache F; Luccioli F; Shoenfeld Y
    Isr Med Assoc J; 2005 Dec; 7(12):778-80. PubMed ID: 16382698
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new testing platform using fingerstick blood for quantitative antibody response evaluation after SARS-CoV-2 vaccination.
    Du J; Zhang D; Pathakamuri JA; Kuebler D; Yang Y; Loginova Y; Chu E; Madej R; Neves JV; Singer B; Radke H; Spencer N; Rizk E; Zhang A; Lu CM; Sha MY
    Emerg Microbes Infect; 2022 Dec; 11(1):250-259. PubMed ID: 34951566
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Robust validation and performance comparison of immunogenicity assays assessing IgG and neutralizing antibodies to SARS-CoV-2.
    Bonhomme ME; Bonhomme CJ; Strelow L; Chaudhari A; Howlett A; Breidenbach C; Hester J; Hammond C; Fuzy M; Harvey L; Swanner V; Ellis J; Greway RR; Pisciella VA; Green T; Kierstead L
    PLoS One; 2022; 17(2):e0262922. PubMed ID: 35130298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heat shock protein 70 and antibodies to heat shock protein 60 are associated with cerebrovascular atherosclerosis.
    Galović R; Flegar-Meštrić Z; Vidjak V; Matokanović M; Barišić K
    Clin Biochem; 2016 Jan; 49(1-2):66-9. PubMed ID: 26500006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan.
    Nakano Y; Kurano M; Morita Y; Shimura T; Yokoyama R; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
    Sci Rep; 2021 Feb; 11(1):2776. PubMed ID: 33531605
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Performance assessment of seven SARS-CoV-2 IgG enzyme-linked immunosorbent assays.
    Deshpande K; Pt U; Kaduskar O; Vijay N; Rakhe A; Vidhate S; Khutwad K; Deshpande GR; Tilekar B; Saka S; Gadekar K; Patil R; Yadav P; Potdar V; Gurav Y; Gupta P; Kaur H; Narayan J; Sapkal G; Abraham P
    J Med Virol; 2021 Dec; 93(12):6696-6702. PubMed ID: 34331713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.